C-reactive protein identifies patients at low risk of anastomotic leak after esophagectomy
- PMID: 36207546
- DOI: 10.1007/s00423-022-02703-5
C-reactive protein identifies patients at low risk of anastomotic leak after esophagectomy
Abstract
Purpose: Fast-track protocols are increasingly used after digestive surgery. After esophagectomy, the gravity and the fear of anastomotic leak may be an obstacle to generalization of such protocols. C-reactive protein (CRP) might be a reliable tool to identify patients at low risk of anastomotic leak after esophagectomy, so that they can be safely included in a fast-track program. The aim of our retrospective bicentric study is to evaluate the interest of C-reactive protein measurement for the early diagnosis of anastomotic leak after esophagectomy.
Methods: Patients having undergone Ivor-Lewis procedure between January 2009 and September 2017 were included in this bicentric retrospective study. CRP values were recorded between postoperative day 3 (POD 3) and postoperative day 5 (POD 5). All postoperative complications were recorded, and the primary endpoint was anastomotic leak.
Results: We included 585 patients. Among them, 241 (41.2%) developed infectious complications and 69 patients (11.8%) developed anastomotic leak. CRP had the best predictive value on POD 5 (AUC = 0.74; 95% CI: 0.67-0.81). On POD 5, a cut-off value of 130 mg/L yielded a sensitivity of 87%, a specificity of 51%, and a negative predictive value of 96% for the detection of anastomotic leak.
Conclusions: CRP may help in identifying patients at very low risk of anastomotic leak after esophagectomy. Patients with CRP values < 130 mg/L on POD 5 can safely undertake an enhanced recovery protocol.
Keywords: Anastomotic leak; C-reactive protein; Esophageal cancer; Esophagectomy.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- Mariette C, Piessen G, Briez N, Gronnier C, Triboulet JP (2011) Oesophagogastric junction adenocarcinoma: which therapeutic approach? Lancet Oncol 12:296–305. https://doi.org/10.1016/S1470-2045(10)70125-X - DOI
-
- Lordick F, Mariette C, Haustermans K, Obermannová R, Arnold D (2016) Oesophageal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 27:50–57. https://doi.org/10.1093/annonc/mdw329 - DOI
-
- Lledo G, Mariette C, Raoul JL, Dahan L, Landi B, Conroy T, et al. (2016) Cancer de l’oesophage. https://www.snfge.org/content/1-cancer-de-loesophage . Accessed 25 July 2022
-
- Kehlet H, Wilmore DW (2002) Multimodal strategies to improve surgical outcome. Am J Surg 183:630–641. https://doi.org/10.1016/S0002-9610(02)00866-8 - DOI
-
- Wilmore DW, Kehlet H (2001) Management of patients in fast track surgery. BMJ 322:473–476. https://doi.org/10.1136/bmj.322.7284.473 - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
